鴻利智匯(300219.SZ):將在廣州市花都區投建鴻利光電LED新型背光顯示項目
格隆匯 6 月 17日丨鴻利智匯(300219.SZ)公佈,為了進一步加強公司在LED產業鏈領域的佈局,公司於2020年6月17日與廣州市花都區人民政府簽訂了《合作協議》。公司將在花都區投資建設鴻利光電LED新型背光顯示項目,主要投資內容有Mini LED背光與顯示、MicroLED、新型顯示器件及模組、新型顯示配套器件等。項目投資分兩期,第一期投資金額約為1.5億元,資金來源為公司自籌資金,第一期完全達產後年產值約6億元,該項目將由公司旗下控股子公司負責實施,第二期投資金額暫未確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.